Skip to content

Vilazodone

SSRI/5-HT1A partial agonist • Last reviewed 2025-09-26

Brands: Viibryd

Sources updated 2025 • 1 references

Summary

General Information

Indicated for: Major depressive disorder. SSRI/5-HT1A partial agonist

Dosage & Administration

Typical dose range: 20–40 mg once daily with food

Indications (label)

Major depressive disorder.

View labelExact

Mechanism (brief)

Serotonin reuptake inhibitor and 5-HT1A receptor partial agonist.

Metabolism & Half‑life

  • Metabolism: Primarily CYP3A4; minor CYP2C19 and CYP2D6.
  • Half‑life: ~25 h.

Therapeutic Drug Monitoring (TDM)

Recommended: No

References